![]() |
Volumn 30, Issue 11, 2001, Pages 856-865
|
Pharmacotherapy of osteoarthritis;Medikamentöse therapie der arthrose
|
Author keywords
Drugs; Osteoarthritis; Pharmacotherapy
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALPHA TOCOPHEROL;
ANALGESIC AGENT;
ANTIOXIDANT;
ANTIRHEUMATIC AGENT;
BLOCKING AGENT;
CYCLOOXYGENASE 2 INHIBITOR;
CYTOKINE RECEPTOR;
GLUCOCORTICOID;
HOX ALPHA;
HYALURONIC ACID;
IBUPROFEN;
MISOPROSTOL;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEPRAZOLE;
ORTHOKIN;
PARACETAMOL;
RANITIDINE;
TRAMADOL;
UNCLASSIFIED DRUG;
ANALGESIC ACTIVITY;
ANTIINFLAMMATORY ACTIVITY;
CARTILAGE DEGENERATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDICATION;
DRUG QUALITY;
GASTROINTESTINAL TOXICITY;
HIGH RISK POPULATION;
HUMAN;
INFLAMMATION;
LONG TERM CARE;
OSTEOARTHRITIS;
PAIN;
PROPHYLAXIS;
QUALITY OF LIFE;
REVIEW;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
SYMPTOM;
TREATMENT INDICATION;
ANALGESICS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CLINICAL TRIALS;
GLUCOCORTICOIDS;
HUMANS;
HYALURONIC ACID;
INJECTIONS, INTRA-ARTICULAR;
OSTEOARTHRITIS;
TREATMENT OUTCOME;
|
EID: 0035213019
PISSN: 00854530
EISSN: None
Source Type: Journal
DOI: 10.1007/s001320170022 Document Type: Review |
Times cited : (15)
|
References (32)
|